News
PIVOT-PO Phase 3 trial evaluating tebipenem Hbr in complicated urinary tract infection (cUTI) patients stopped early for ...
One of the most significant biomedical achievements of the 21st century, mRNA vaccines have reshaped the world’s ability to ...
The FDA has agreed to fast-track its review of gepotidacin, an oral antibiotic already approved for urinary tract infections, ...
South Korea’s pharma industry has a valuable pool of promising drugs, but China still leads the way in out-licensing deals.
GSK and CureVac will together receive $740 million, as well as royalties on sales of COVID-19 vaccines in the US ...
8h
TipRanks on MSNGSK Executives Acquire Shares Under Reward Plan
GSK plc announced the acquisition of ordinary shares by several key executives under the Company’s Share Reward Plan. This transaction, conducted on the London Stock Exchange, involved the purchase of ...
16h
TipRanks on MSNGSK Enhances Shareholder Value with Strategic Buyback
GlaxoSmithKline ( ($GB:GSK) ) just unveiled an announcement. GSK plc has announced the purchase of 494,426 of its own ordinary shares as part of ...
Austin family advocates for getting fully vaccinated for meningococcal disease after daughter lost her legs and fingers as a ...
The GSK Flovent example highlights the consequences for patients and pharma of the decision to eliminate the Medicaid rebate cap.
British drugmaker GSK said on Monday that the U.S. Food and Drug Administration has accepted its application for priority ...
It is not clear whether Prasad will still serve as the agency’s chief medical and scientific officer, Stat reports. Meanwhile, Center for Drug Evaluation and Research staff grill top drug regulator ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results